Targeting of injectable drug nanocrystals

Molecular Pharmaceutics

Volumn 11, Issue 6, 2014, Pages 1762-1771

  Fuhrmann, Kathrin ^a   Gauthier, Marc A ^b   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

^b INRS EMT   (Canada)

Author keywords

biodistribution; chemotherapy; coating; dissolution; layer by layer; nanocrystal; nanoparticle; poorly soluble drug; shedding; targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; APREPITANT; CAMPTOTHECIN; CYCLODEXTRIN; FENOFIBRATE; FOLIC ACID; GEMCITABINE; ITRACONAZOLE; MEGESTROL ACETATE; MELARSOPROL; NANOCARRIER; NANOCRYSTAL; PACLITAXEL; RAPAMYCIN; STABILIZING AGENT; DRUG; DRUG CARRIER; NANOPARTICLE;

ARTICLE; COMPARATIVE STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG TARGETING; DRUG UPTAKE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; SLOW DRUG RELEASE; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; INJECTION; MEDICINAL CHEMISTRY; NEOPLASMS; PROCEDURES; SOLUBILITY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS; NANOPARTICLES; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 84901798602     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5001247     Document Type: Article

References (76)

1. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C. Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 11460-11464
2. Kang, N.; Perron, M.-È.; Prud'homme, R. E.; Zhang, Y.; Gaucher, G.; Leroux, J.-C. Stereocomplex Block Copolymer Micelles: Core-Shell Nanostructures with Enhanced Stability Nano Lett. 2005, 5, 315-319
3. Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices J. Controlled Release 2001, 70, 1-20
4. Barenholz, Y. Doxil - The First FDA-approved Nano-drug: Lessons Learned J. Controlled Release 2012, 160, 117-134
5. Singla, A. K.; Garg, A.; Aggarwal, D. Paclitaxel and Its Formulations Int. J. Pharm. 2002, 235, 179-192
6. Olson, R. D.; Mushlin, P. S. Doxorubicin Cardiotoxicity: Analysis of Prevailing Hypotheses FASEB J. 1990, 4, 3076-3086
7. Wu, L.; Zhang, J.; Watanabe, W. Physical and Chemical Stability of Drug Nanoparticles Adv. Drug Delivery Rev. 2011, 63, 456-469
8. Junghanns, J.-U. A. H.; Müller, R. H. Nanocrystal Technology, Drug Delivery and Clinical Applications Int. J. Nanomed. 2008, 3, 295-309
9. Muller, R. H.; Keck, C. M. Challenges and Solutions for the Delivery of Biotech Drugs-A Review of Drug Nanocrystal Technology and Lipid Nanoparticles J. Biotechnol. 2004, 113, 151-170
10. Choi, J.-Y.; Yoo, J. Y.; Kwak, H.-S.; Uk Nam, B.; Lee, J. Role of Polymeric Stabilizers for Drug Nanocrystal Dispersions Curr. Appl. Phys. 2005, 5, 472-474
11. Keck, C. M.; Muller, R. H. Drug Nanocrystals of Poorly Soluble Drugs Produced by High Pressure Homogenisation Eur. J. Pharm. Biopharm. 2006, 62, 3-16
12. Rabinow, B. E. Nanosuspensions in Drug Delivery Nat. Rev. Drug Discovery 2004, 3, 785-796
13. Gao, L.; Liu, G.; Ma, J.; Wang, X.; Zhou, L.; Li, X. Drug Nanocrystals: In Vivo Performances J. Controlled Release 2012, 160, 418-430
14. Merisko-Liversidge, E.; Liversidge, G. G. Nanosizing for Oral and Parenteral Drug Delivery: A Perspective on Formulating Poorly-water Soluble Compounds Using Wet Media Milling Technology Adv. Drug Delivery Rev. 2011, 63, 427-440
15. Chan, H.-K.; Kwok, P. C. L. Production Methods for Nanodrug Particles Using the Bottom-up Approach Adv. Drug Delivery Rev. 2011, 63, 406-416
16. Kenth, S.; Sylvestre, J.-P.; Fuhrmann, K.; Meunier, M.; Leroux, J.-C. Fabrication of Paclitaxel Nanocrystals by Femtosecond Laser Ablation and Fragmentation J. Pharm. Sci. 2011, 100, 1022-1030
17. Sylvestre, J.-P.; Tang, M.-C.; Furtos, A.; Leclair, G.; Meunier, M.; Leroux, J.-C. Nanonization of Megestrol Acetate by Laser Fragmentation in Aqueous Milieu J. Controlled Release 2011, 149, 273-280
18. Chattopadhyay, P.; Gupta, R. B. Production of Antibiotic Nanoparticles Using Supercritical CO2 as Antisolvent with Enhanced Mass Transfer Ind. Eng. Chem. Res. 2001, 40, 3530-3539
19. Chattopadhyay, P.; Gupta, R. B. Production of Griseofulvin Nanoparticles Using Supercritical CO2 Antisolvent with Enhanced Mass Transfer Int. J. Pharm. 2001, 228, 19-31
20. Date, A. A.; Patravale, V. B. Current Strategies for Engineering Drug Nanoparticles Curr. Opin. Colloid Interface Sci. 2004, 9, 222-235
21. Merisko-Liversidge, E. M.; Liversidge, G. G. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds Toxicol. Pathol. 2008, 36, 43-48
22. Merisko-Liversidge, E.; Liversidge, G. G.; Cooper, E. R. Nanosizing: A Formulation Approach for Poorly-water-soluble Compounds Eur. J. Pharm. Sci. 2003, 18, 113-120
23. Van Eerdenbrugh, B.; Van den Mooter, G.; Augustijns, P. Top-down Production of Drug Nanocrystals: Nanosuspension Stabilization, Miniaturization and Transformation Into Solid Products Int. J. Pharm. 2008, 364, 64-75
24. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular Permeability in a Human Tumor Xenograft: Molecular Size Dependence and Cutoff Size Cancer Res. 1995, 55, 3752-3756
25. Van Eerdenbrugh, B.; Vermant, J.; Martens, J. A.; Froyen, L.; Van Humbeeck, J.; Augustijns, P.; Van den Mooter, G. A Screening Study of Surface Stabilization During the Production of Drug Nanocrystals J. Pharm. Sci. 2009, 98, 2091-2103
26. Cerdeira, A. M.; Werner, I. A.; Mazzotti, M.; Gander, B. Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy Drug Dev. Ind. Pharm. 2012, 38, 1360-1370
27. Peltonen, L.; Hirvonen, J. Pharmaceutical Nanocrystals by Nanomilling: Critical Process Parameters, Particle Fracturing and Stabilization Methods J. Pharm. Pharmacol. 2010, 62, 1569-1579
28. Cerdeira, A. M.; Mazzotti, M.; Gander, B. Miconazole Nanosuspensions: Influence of Formulation Variables on Particle Size Reduction and Physical Stability Int. J. Pharm. 2010, 396, 210-218
29. Ploehn, H. J.; Russel, W. B. Interactions Between Colloidal Particles and Soluble Polymers. In Advances in Chemical Engineering; James, W., Ed.; Academic Press: San Diego, 1990; pp 137-228.
30. Agarwal, A.; Lvov, Y.; Sawant, R.; Torchilin, V. Stable Nanocolloids of Poorly Soluble Drugs with High Drug Content Prepared Using the Combination of Sonication and Layer-by-layer Technology J. Controlled Release 2008, 128, 255-260
31. Fuhrmann, K.; Połomska, A.; Aeberli, C.; Castagner, B.; Gauthier, M. A.; Leroux, J.-C. Modular Design of Redox-Responsive Stabilizers for Nanocrystals ACS Nano 2013, 7, 8243-8250
32. Shchekin, A. K.; Rusanov, A. I. Generalization of the Gibbs-Kelvin-Köhler and Ostwald-Freundlich Equations for a Liquid Film on a Soluble Nanoparticle J. Chem. Phys. 2008, 129, 154116
33. Hollis, C. P.; Weiss, H. L.; Leggas, M.; Evers, B. M.; Gemeinhart, R. A.; Li, T. Biodistribution and Bioimaging Studies of Hybrid Paclitaxel Nanocrystals: Lessons Learned of the EPR Effect and Image-guided Drug Delivery J. Controlled Release 2013, 172, 12-21
34. Moreno-Aspitia, A.; Perez, E. A. North Central Cancer Treatment Group N0531: Phase II Trial of Weekly Albumin-Bound Paclitaxel (ABI-007; Abraxane) in Combination with Gemcitabine in Patients with Metastatic Breast Cancer Clin. Breast Cancer 2005, 6, 361-364
35. Desai, N. P.; Tao, C.; Yang, A.; Louie, L.; Soon-shiong, P. Formulations of Pharmacological Agents, Methods for the Preparation Thereof and Methods for the Use Thereof. U. S. Patent 8137684 B2, 2012.
36. Liu, F.; Park, J.-Y.; Zhang, Y.; Conwell, C.; Liu, Y.; Bathula, S. R.; Huang, L. Targeted Cancer Therapy with Novel High Drug-loading Nanocrystals J. Pharm. Sci. 2010, 99, 3542-3551
37. Shegokar, R.; Singh, K. K. Surface Modified Nevirapine Nanosuspensions for Viral Reservoir Targeting: In Vitro and In Vivo Evaluation Int. J. Pharm. 2011, 421, 341-352
38. Zhang, H.; Hollis, C. P.; Zhang, Q.; Li, T. Preparation and Antitumor Study of Camptothecin Nanocrystals Int. J. Pharm. 2011, 415, 293-300
39. Ben Zirar, S.; Astier, A.; Muchow, M.; Gibaud, S. Comparison of Nanosuspensions and Hydroxypropyl-β-cyclodextrin Complex of Melarsoprol: Pharmacokinetics and Tissue Distribution in Mice Eur. J. Pharm. Biopharm. 2008, 70, 649-656
40. Vergara, D.; Bellomo, C.; Zhang, X.; Vergaro, V.; Tinelli, A.; Lorusso, V.; Rinaldi, R.; Lvov, Y. M.; Leporatti, S.; Maffia, M. Lapatinib/Paclitaxel Polyelectrolyte Nanocapsules for Overcoming Multidrug Resistance in Ovarian Cancer Nanomedicine 2012, 8, 891-899
41. Cho, Y. W.; Lee, J.; Lee, S. C.; Huh, K. M.; Park, K. Hydrotropic Agents for Study of In Vitro Paclitaxel Release from Polymeric Micelles J. Controlled Release 2004, 97, 249-257
42. Kadiu, I.; Nowacek, A.; McMillan, J.; Gendelman, H. E. Macrophage Endocytic Trafficking of Antiretroviral Nanoparticles Nanomedicine 2011, 6, 975-994
43. Nowacek, A.; McMillan, J.; Miller, R.; Anderson, A.; Rabinow, B.; Gendelman, H. Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics J. Neuroimmune Pharmacol. 2010, 5, 592-601
44. Nowacek, A. S.; Balkundi, S.; McMillan, J.; Roy, U.; Martinez-Skinner, A.; Mosley, R. L.; Kanmogne, G.; Kabanov, A. V.; Bronich, T.; Gendelman, H. E. Analyses of Nanoformulated Antiretroviral Drug Charge, Size, Shape and Content for Uptake, Drug Release and Antiviral Activities in Human Monocyte-derived Macrophages J. Controlled Release 2011, 150, 204-211
45. Bui, D. T.; Nicolas, J.; Maksimenko, A.; Desmaele, D.; Couvreur, P. Multifunctional Squalene-based Prodrug Nanoparticles for Targeted Cancer Therapy Chem. Commun. 2014, 10.1039/c3cc47427e
46. Mouton, J. W.; van Peer, A.; de Beule, K.; Van Vliet, A.; Donnelly, J. P.; Soons, P. A. Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects After Single and Multiple Doses of a Novel Formulation Antimicrob. Agents Chemother. 2006, 50, 4096-4102
47. Tian, X.; Li, H.; Zhang, D.; Shen, J.; Jia, L.; Zheng, D.; Liu, G.; Hao, L.; Shen, Y.; Zhang, Q. Parenteral nanosuspension of a novel synthesized antitumor candidate: Investigation of tissue biodistributions and plasma pharmacokinetics Colloids Surf., A: Physicochem. Eng. Aspects 2013, 436, 868-872
48. Sharma, P.; Zujovic, Z. D.; Bowmaker, G. A.; Denny, W. A.; Garg, S. Evaluation of a Crystalline Nanosuspension: Polymorphism, Process Induced Transformation and In Vivo Studies Int. J. Pharm. 2011, 408, 138-151
49. Sigfridsson, K.; Forssén, S.; Holländer, P.; Skantze, U.; de Verdier, J. A Formulation Comparison, Using a Solution and Different Nanosuspensions of a Poorly Soluble Compound Eur. J. Pharm. Biopharm. 2007, 67, 540-547
50. Tian, X.; Li, H.; Zhang, D.; Liu, G.; Jia, L.; Zheng, D.; Shen, J.; Shen, Y.; Zhang, Q. Nanosuspension for parenteral delivery of a p-terphenyl derivative: Preparation, characteristics and pharmacokinetic studies Colloids Surf., B: Biointerfaces 2013, 108, 29-33
51. Ganta, S.; Paxton, J. W.; Baguley, B. C.; Garg, S. Formulation and Pharmacokinetic Evaluation of an Asulacrine Nanocrystalline Suspension for Intravenous Delivery Int. J. Pharm. 2009, 367, 179-186
52. Gao, L.; Zhang, D.; Chen, M.; Duan, C.; Dai, W.; Jia, L.; Zhao, W. Studies on Pharmacokinetics and Tissue Distribution of Oridonin Nanosuspensions Int. J. Pharm. 2008, 355, 321-327
53. Rabinow, B.; Kipp, J.; Papadopoulos, P.; Wong, J.; Glosson, J.; Gass, J.; Sun, C.-S.; Wielgos, T.; White, R.; Cook, C. Itraconazole IV Nanosuspension Enhances Efficacy through Altered Pharmacokinetics in the Rat Int. J. Pharm. 2007, 339, 251-260
54. Shegokar, R.; Müller, R. H. Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 2010, 399, 129-139
55. Sanchez, V. C.; Pietruska, J. R.; Miselis, N. R.; Hurt, R. H.; Kane, A. B. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1, 511-529
56. Baert, L.; van't Klooster, G.; Dries, W.; François, M.; Wouters, A.; Basstanie, E.; Iterbeke, K.; Stappers, F.; Stevens, P.; Schueller, L. Development of a Long-acting Injectable Formulation with Nanoparticles of Rilpivirine (TMC278) for HIV Treatment Eur. J. Pharm. Biopharm. 2009, 72, 502-508
57. Liu, Y.; Huang, L.; Liu, F. Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer Mol. Pharmaceutics 2010, 7, 863-869
58. Dintaman, J. M.; Silverman, J. A. Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) Pharm. Res. 1999, 16, 1550-1556
59. Zhang, H.; Wang, X.; Dai, W.; Gemeinhart, R. A.; Zhang, Q.; Li, T. Pharmacokinetics and Treatment Efficacy of Camptothecin Nanocrystals on Lung Metastasis Mol. Pharmaceutics 2013, 11, 226-233
60. Karmali, P. P.; Kotamraju, V. R.; Kastantin, M.; Black, M.; Missirlis, D.; Tirrell, M.; Ruoslahti, E. Targeting of Albumin-embedded Paclitaxel Nanoparticles to Tumors Nanomedicine 2009, 5, 73-82
61. Gardner, E. R.; Dahut, W. L.; Scripture, C. D.; Jones, J.; Aragon-Ching, J. B.; Desai, N.; Hawkins, M. J.; Sparreboom, A.; Figg, W. D. Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel Clin. Cancer. Res. 2008, 14, 4200-4205
62. Deng, J.; Huang, L.; Liu, F. Understanding the Structure and Stability of Paclitaxel Nanocrystals Int. J. Pharm. 2010, 390, 242-249
63. Parrish, B.; Breitenkamp, R. B.; Emrick, T. PEG- and Peptide-Grafted Aliphatic Polyesters by Click Chemistry J. Am. Chem. Soc. 2005, 127, 7404-7410
64. Kim, S.; Lee, J. Folate-targeted Drug-delivery Systems Prepared by Nano-comminution Drug Dev. Ind. Pharm. 2011, 37, 131-138
65. Fuhrmann, K.; Schulz, J. D.; Gauthier, M. A.; Leroux, J.-C. PEG Nanocages as Non-sheddable Stabilizers for Drug Nanocrystals ACS Nano 2012, 6, 1667-1676
66. Trachootham, D.; Alexandre, J.; Huang, P. Targeting Cancer Cells by ROS-mediated Mechanisms: a Radical Therapeutic Approach? Nat. Rev. Drug Discovery 2009, 8, 579-591
67. Lin, M. T.; Beal, M. F. Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases Nature 2006, 443, 787-795
68. Lu, Y.; Wang, Z.-h.; Li, T.; McNally, H.; Park, K.; Sturek, M. Development and Evaluation of Transferrin-stabilized Paclitaxel Nanocrystal Formulation J. Controlled Release 2014, 176, 76-85
69. Ai, H.; Jones, S. A.; de Villiers, M. M.; Lvov, Y. M. Nano-encapsulation of Furosemide Microcrystals for Controlled Drug Release J. Controlled Release 2003, 86, 59-68
70. Qiu, X.; Leporatti, S.; Donath, E.; Möhwald, H. Studies on the Drug Release Properties of Polysaccharide Multilayers Encapsulated Ibuprofen Microparticles Langmuir 2001, 17, 5375-5380
71. Sukhorukov, G. B.; Brumen, M.; Donath, E.; Möhwald, H. Hollow Polyelectrolyte Shells: Exclusion of Polymers and Donnan Equilibrium J. Phys. Chem. B 1999, 103, 6434-6440
72. Shutava, T. G.; Pattekari, P. P.; Arapov, K. A.; Torchilin, V. P.; Lvov, Y. M. Architectural Layer-by-layer Assembly of Drug Nanocapsules with PEGylated Polyelectrolytes Soft Matter 2012, 8, 9418-9427
73. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M. Accumulation of Sub-100 nm Polymeric Micelles in Poorly Permeable Tumours Depends on Size Nat. Nanotechnol. 2011, 6, 815-823
74. Wong, C.; Stylianopoulos, T.; Cui, J.; Martin, J.; Chauhan, V. P.; Jiang, W.; Popović, Z.; Jain, R. K.; Bawendi, M. G.; Fukumura, D. Multistage Nanoparticle Delivery System for Deep Penetration into Tumor Tissue Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 2426-2431
75. Arias, J. L.; Reddy, L. H.; Couvreur, P. Magnetoresponsive Squalenoyl Gemcitabine Composite Nanoparticles for Cancer Active Targeting Langmuir 2008, 24, 7512-7519
76. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs Science 2010, 328, 1031-1035